Gallium (Ga) nitrate has been shown to attenuate immune-mediated tissue destruction in models of neurological autoimmunity. Based upon these observa tions, we evaluated the efficacy of Ga nitrate in attenuating the inflammatory response and modifying clinical recovery in an experimental model of traumatic spinal cord injury (SCI). Using a randomized, double-blind, placebo-controlled design, 12 adult female Spraque-Dawley rats received injections of either Ga nitrate (n = 8) or saline (n = 4) following experimental SCI. Ga treated animals received 30 mg/kg elemental Ga followed by weekly injections of 10 mg/kg elemental Ga. There were no observable differences between the Ga treated and the saline control groups using various behavioral paradigms examined during the study period. Histological and immunocytochemical data qualitatively showed no observable differences between Ga treated ( n = 4) and control 
Such observations give impetus to further evaluation of this immunologic interaction. Gallium (Ga) is a group IlIA transitional element with multiple valences which in one of its salt forms (ie Ga nitrate) can inhibit macrophage and lymphocyte activity under experimental conditions.13-15 Ga nitrate has shown efficacy in suppression of experi mental autoimmune encephalomyelitis,15 as well as in prevention of adjuvant arthri tis 13 . 1 6 in rats. The use of Ga salts in the clinical treatment of Paget's disease may inhibit the function of osteoclasts, macro phage-like cells derived from bone marrow precursors. 13 .1" The present pilot study was designed to determine the efficacy of Ga nitrate in modifying SCI and spinal cord recovery in an experimental SCI model.
Methods

Animals
Twelve adult female Sprague-Dawley rats weighing between 250 and 275 g were util ized (Harlan Sprague-Dawley. Inc, Indian apolis, IN). All animals were housed in a controlled environment with regularly cycled light/dark periods of 12 hours. The animals were familiarized with their en vironment prior to the onset of the project, and allowed free access to food and water. Approval of the research protocol and treatment of the animals throughout the duration of the study was in accordance with the doctrines of the Animal Review Com mittee at The Ohio State University.
Spinal cord impactor device
Contusion lesions in the spinal cords of the animals were produced by our Ohio State impact device.17 This impact device delivers controlled displacement. force. and ac celeration of the impactor probe, while allowing feedback of these parameters.17.1� Two highly sensitive transducers are at tached to the impactor probe used to proGallium nitrate and spinal cord injury 87 duce experimental spinal cord injury in order to determine a known starting point for injury production, produce a known and reproducible displacement profile during the injury, and estimate the force needed to compress the spinal cord by the same amount for each animal. Such force feed back is quite useful in determining the biomechanical properties of the spinal com partment during the injury and in prevent ing the impactor probe from contacting adjacent tissue during the impact phase. It has shown previously that this impact device produces predictable incomplete spinal cord injuries of similar severity between animal groups.
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Production of SCI lesions
The animals were anesthetized with an intraperitoneal solution of ketamine hydro chloride (SO mg/kg) and xylazine (10 mg/kg). A partial dorsal laminectomy was then performed at TS-9, ensuring minimal disturbance of the dura. The laminectomy site was limited to one vertebral level. which was slightly larger than the tip of the impactor probe (7 mm2).
Following laminectomy, the animals were mounted in a spinal frame in which the nearby dorsal processes were rigidly fixed, as described previously. 1 9 -2 1 A Ling shaker (Model V203/S, Ling Dynamics Systems Corp) was used to compress the spinal cord dorsal surface approximately 1. 1 mm over a 23 ms time period. The injury process in volves approximately 11 ms to produce the full impact and reach peak compression, followed by removal of the impactor probe from contact with the dural surface of the cord over the remaining 12 ms time period. Muscle and skin wounds were then closed in layers. Following surgery. the animals were placed on a heating pad and allowed to recover spontaneously. They were given fluids to maintain hydration and were al lowed to eat ad libitum as they recovered. Bladders were expressed at least three times daily until reflexes returned (usually within 2 weeks). Antibiotics were administered orally (4. 0 mg trimethoprim; 20 mg sulfadia zine. daily) from 2 days preoperatively until reflex bladder function returned. served as a control. Several sections were counterstained with cresyl violet or neutral red to visualize gliosis and mass inflammat ory infiltrate. Myelin profiles of adjacent sections were visualized using luxol fast blue (LFB) staining. Qualitative assessments of gliotic scarring, mass inflammatory infil trate, and myeline profiles were performed by direct visualization.
Statistical analysis
A two dimensional analysis of variance (ANOV A) was performed on mean beha vioral values between treatment and control groups for the various paradigms utilized in the study.
Results
Eight rats received Ga nitrate Injections and four received normal saline. There were no differences observed between the Ga treated and the saline control groups using the behavioral paradigms examined during the study period (ie 28 days postinjury). The
Tarlov open-field test scores, average in clined plane scores, and average grid walk ing scores are depicted in Figures la-c. P values of less than 0.05 were considered significant. Histological and immunocytochemical data similarly showed no qualitatively ob servable differences between Ga treated (n = 4) and control (n = 2) groups sacri ficed 18 days following SCI. We observed MHC class II antigen reaction on both macrophages and microglia in the injured spinal cord tissues which was qualitatively indistinguishable between control and Ga treated animals. Gliotic scarring and inflam matory cell density were also indistinguish able between groups.
Discussion
Ga is a group IlIA transitional element clinically used in the diagnosis of suspected neoplastic27 and inflammatory conditions, 2 R as well as in the treatment of hypercalcemia associated with malignancy. [29] [30] [31] This metal is reported to have efficacy in the treatment of certain neoplasms,29.32 and has profound effects upon bone metabolism. [33] [34] [35] [36] In addi tion to its clinical applications, Ga appears to have immunologic activity. 13 . 15 , 16 3 7
In the current pilot study, we postulated that Ga nitrate, by suppressing macrophage function, could modulate the inflammatory sequelae of acute traumatic SCI and im prove neurologic recovery in the experi mental model. Blight 2 --U8 has suggested that the macrophage could be a key cellular component in the process of secondary injury following acute traumatic SCI. Cor relations of hypervascularity with declining neurologic scores and the delayed onset of functional loss in animals following adminis tration of a macrophage toxin, support this hypothesis.
Our initial attempts to use Ga nitrate as an immunosuppressive agent following ex perimental SCI in rodents have met with negative results. Using three behavioral paradigms, we were unable to observe any significant differences in recovery of spinal cord function following spinal injury. Simi larly, no significant histologic differences were observed. The expression of MHC class II antigen from microglia and macro phages observed in our SCI model signifies a state of activation.39 MHC class II antigen is normally not expressed in the rat central nervous system by these cells except in the presence of injury or inflammatory stimuli. Microglial and macrophage activation as determined by antibody visualization of MHC class II antigen was indistinguishable between the Ga treated and control groups.
These findings differed from our initial hypothesis and were unexpected given that Ga indeed appears to interfere with the function of both macrophages13,14 and Iym phocytes.13.IS. 37 Based upon the findings in the present pilot study, it is difficult to ascertain whether Ga nitrate has any therapeutic value in the treatment of acute traumatic SCI. The cascade of events involved in the acute inflammatory reaction following trau matic SCI are multiple (and nonexclusive)3 and inhibition of any aspect(s) of that process by Ga nitrate may not be significant enough to impart a notable clinical re sponse. However, before reaching a conclu sion regarding the efficacy of Ga, several caveats of the present study must be ad dressed.
We administered Ga nitrate in dosing schedules similar to those used in other studies demonstrating the clinical efficacy of Ga nitrate in rodent models of experimental adjuvant arthritis13 and experimental auto immune encephalomyelitis.15 Perhaps dif ferent dosages and/or dosage schedules of Ga nitrate than those employed are needed to observe a significant therapeutic re sponse. It is unclear as to whether Ga crosses the blood-brain barrier (BBB) in uninjured animals, and to what extent it crosses following SCI. In order to determine the extent to which Ga enters uninjured or injured CNS parenchymal tissue, Ga con jugated to fluorescent or peroxidase tracers, or radiolabeled Ga67 could be utilized. In our model of SCI, we are uncertain of the duration of time during which the perme ability to the BBB is altered, and assessment of BBB permeability over time would be helpful.
Studies on gallium's ability to attenuate macrophage function have thus far been limited to macrophages of bone marrow origin. At present, a controversy still exists as to the origin of the CNS microglia cells. The possibility that microglia are of a mesodermal origin as opposed to being formed from bone marrow precursors, spe cifically infiltrating monocytes, suggests that certain membrane receptor mechanisms References necessary for Ga uptake may not be present on resident microglial cells. Therefore, microglial mediated cytotoxicity may not be affected by Ga. Since the exact mechanism with which Ga exerts its effects are not fully elucidated, further in vitro studies would be helpful in characterizing the effect of Ga on microglial cells.
Although the efficacy of Ga in the present study of experimental SCI was not demons trated, the potential of Ga to attenuate inflammatory-mediated reactions remains an exciting possibility in the area of SCI. These preliminary results hopefully will not discourage future research endeavors in this regard.
